logo
episode-header-image
Aug 18
29m 55s

Semaglutide Versus Dulaglutide or Empagl...

AMERICAN COLLEGE OF PHYSICIANS
About this episode
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 
Up next
Nov 17
Palliative Care: A Family Perspective
Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay. 
19m 37s
Nov 3
What You May Have Missed in 2024: Part 3
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024." 
15m 33s
Oct 20
What You May Have Missed in 2024 - Part 2
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024." 
13m 52s
Recommended Episodes
Jan 2024
ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes
<div class="OutlineElement Ltr SCXW246962676 BCX0"> <p class="Paragraph SCXW246962676 BCX0"><span class= "TextRun SCXW246962676 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW246962676 BCX0">The SELECT trial extends findings from</span> < ... Show More
12m 54s
Aug 2024
Type 2 diabetes
Type 2 diabetes is common. It accounts for over 90% of all diabetes, and has a prevalence of 8.5% in the US. And complications are common as well - from blindness to amputation to chronic kidney disease. So it is important that we get the diagnosis and management of this conditio ... Show More
24m 21s
Jan 2025
Relationship Between Intermittent Hypoxia, COPD and Comorbidities
Dr. Amy Attaway and Dr. Dan Culver review the emerging relationship between COPD patients who have intermittent hypoxemia and an increase they have in co-morbidities and mortality. They discuss how multiple associative studies suggest that intermittent hypoxemia may impact muscul ... Show More
21m 50s
Feb 2024
Diabetes Core Update March 2024
<p>Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approxi ... Show More
24m 6s
Feb 2025
#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
<p><a href= "https://peterattiamd.com/ralphdefronzo/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250224-pod-ralphdefronzo&utm_content=250224-pod-ralphdefronzo-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/ ... Show More
2h 26m
Aug 2024
Diabetes Core Update Sept 2024
<p>Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approxi ... Show More
23m 54s
Aug 14
Common Medications and Diabetic Macular Edema
Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ... Show More
18m 26s
Mar 2023
Cholesterol and Diabetes Q&A
There is no shortage of questions about these two increasingly common medical conditions: high cholesterol and diabetes. 
8m 41s
Apr 2025
Special Edition - Early Identification and Delay of Type 1 Diabetes April 2025
In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi. Presented by: Neil Skolnik, M.D., Professor of Family and Co ... Show More
26m 33s
Aug 2024
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398   
2m 17s